| Literature DB >> 31685984 |
Gonçalo Rodrigues1,2, Ayuko Hoshino1,3,4, Candia M Kenific1, Irina R Matei1, Loïc Steiner1,5, Daniela Freitas1,6,7,8, Han Sang Kim1,9, Peter R Oxley10, Ilana Scandariato1, Irene Casanova-Salas1, Jinxiang Dai11, Chaitanya R Badwe12, Brunilde Gril13, Milica Tešić Mark14, Brian D Dill14, Henrik Molina14, Haiying Zhang1, Alberto Benito-Martin1, Linda Bojmar1, Yonathan Ararso1, Katharine Offer1, Quincey LaPlant1, Weston Buehring1, Huajuan Wang1, Xinran Jiang1, Tyler M Lu12,15, Yuan Liu16, Joshua K Sabari17, Sandra J Shin18, Navneet Narula18, Paula S Ginter18, Vinagolu K Rajasekhar19, John H Healey20, Etienne Meylan5, Bruno Costa-Silva21, Shizhen Emily Wang22, Shahin Rafii12, Nasser Khaled Altorki23, Charles M Rudin17, David R Jones16, Patricia S Steeg13, Héctor Peinado1,24, Cyrus M Ghajar11, Jacqueline Bromberg25,26, Maria de Sousa27,28, David Pisapia29, David Lyden30.
Abstract
The development of effective therapies against brain metastasis is currently hindered by limitations in our understanding of the molecular mechanisms driving it. Here we define the contributions of tumour-secreted exosomes to brain metastatic colonization and demonstrate that pre-conditioning the brain microenvironment with exosomes from brain metastatic cells enhances cancer cell outgrowth. Proteomic analysis identified cell migration-inducing and hyaluronan-binding protein (CEMIP) as elevated in exosomes from brain metastatic but not lung or bone metastatic cells. CEMIP depletion in tumour cells impaired brain metastasis, disrupting invasion and tumour cell association with the brain vasculature, phenotypes rescued by pre-conditioning the brain microenvironment with CEMIP+ exosomes. Moreover, uptake of CEMIP+ exosomes by brain endothelial and microglial cells induced endothelial cell branching and inflammation in the perivascular niche by upregulating the pro-inflammatory cytokines encoded by Ptgs2, Tnf and Ccl/Cxcl, known to promote brain vascular remodelling and metastasis. CEMIP was elevated in tumour tissues and exosomes from patients with brain metastasis and predicted brain metastasis progression and patient survival. Collectively, our findings suggest that targeting exosomal CEMIP could constitute a future avenue for the prevention and treatment of brain metastasis.Entities:
Mesh:
Substances:
Year: 2019 PMID: 31685984 PMCID: PMC7354005 DOI: 10.1038/s41556-019-0404-4
Source DB: PubMed Journal: Nat Cell Biol ISSN: 1465-7392 Impact factor: 28.824